Showing results 15 to 34 of 119
< previous
next >
| Issue Date | Title | Author(s) |
| 2022-01-28 | Biological databases and tools for neurological disorders. | Usman, MB; Ojha, S; Jha, SK; Chellappan, DK; Gupta, G; Singh, SK; Dua, K; Roychoudhury, S; Kumar, N; Khan, FA; Dureja, H; Upadhye, V; Zacconi, F; Prasanna, P; Kesari, KK; Ashraf, GM; Alexiou, A; Jha, NK |
| 2022-06-13 | Biomedical applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches. | Kaur, J; Gulati, M; Zacconi, F; Dureja, H; Loebenberg, R; Ansari, MS; AlOmeir, O; Alam, A; Chellappan, DK; Gupta, G; Jha, NK; Pinto, TDJA; Morris, A; Choonara, YE; Adams, J; Dua, K; Singh, SK |
| 2021-06-23 | Biosynthetic exosome nanoparticles isolation, characterization, and their diagnostic and therapeutic applications | Anand, K; Chandrasekaran, B; Gupta, G; Dureja, H; Singh, SK; Gulati, M; Chellappan, DK; Balasubramanian, B; Femeela, I; Armugam, VA; Dua, K |
| 2024 | Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases. | Solanki, N; Gupta, G; Chellappan, DK; Singh, SK; Gulati, M; Paudel, KR; Hansbro, PM; Dua, K; Bhan, S; Saini, M; Dureja, H |
| 2021-07-01 | Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19 | Jeyaraman, M; Muthu, S; Bapat, A; Jain, R; ES, S; Gulati, A; Channaiah Anudeep, T; Dilip, SJ; Jha, NK; Kumar, D; Kesari, KK; Ojha, S; Dholpuria, S; Gupta, G; Dureja, H; Chellappan, DK; Singh, SK; Dua, K; Jha, SK |
| 2021-03-09 | Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection | Singh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G |
| 2024-04-11 | Cationic cycloamylose based nucleic acid nanocarriers. | Prasher, P; Sharma, M; Agarwal, V; Singh, SK; Gupta, G; Dureja, H; Dua, K |
| - | Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update | Mehta, M; Dhanjal, DS; Paudel, KR; Singh, B; Gupta, G; Rajeshkumar, S; Thangavelu, L; Tambuwala, MM; Bakshi, HA; Chellappan, DK; Pandey, P; Dureja, H; Charbe, NB; Singh, SK; Shukla, SD; Nammi, S; Aljabali, AA; Wich, PR; Hansbro, PM; Satija, S; Dua, K |
| 2019-12-01 | Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system | Pandey, P; Chellappan, DK; Tambuwala, MM; Bakshi, HA; Dua, K; Dureja, H |
| 2021-01-01 | Chapter 30 Biosynthetic exosome nanoparticles isolation, characterization, and their diagnostic and therapeutic applications | Anand, K; Chandrasekaran, B; Gupta, G; Dureja, H; Singh, SK; Gulati, M; Chellappan, DK; Balasubramanian, B; Femeela, I; Arumugam, VA; Dua, K |
| 2022 | Chemical Moieties as Advanced Therapeutics for Targeting Respiratory Disorders | Prasher, P; Sharma, M; Kapoor, DN; Negi, P; Gupta, G; Zacconi, FC; Tambuwala, MM; Mehta, M; Satija, S; Dureja, H; Chellappan, DK; Dua, K |
| 2023-05 | Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization | Dahiya, M; Awasthi, R; Yadav, JP; Sharma, S; Dua, K; Dureja, H |
| 2023-02 | Chitosan-based nano drug delivery system for lung cancer | Kazmi, I; Shaikh, MAJ; Afzal, O; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Al-Abbasi, FA; Pandey, M; Dureja, H; Singh, SK; Dua, K; Gupta, G |
| 2024-01 | CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis | Bhat, AA; Gupta, G; Dahiya, R; Thapa, R; Gahtori, A; Shahwan, M; Jakhmola, V; Tiwari, A; Kumar, M; Dureja, H; Singh, SK; Dua, K; Kumarasamy, V; Subramaniyan, V |
| 2023-01-01 | Clinical Trials and Regulatory Issues of Natural Polymers Employed in Respiratory Disease | Hussian, T; Tripathy, S; Dua, K; Dureja, H |
| 2020-11-30 | Correction: Aljabali, A.A.A.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via down Regulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113. | Aljabali, AAA; Bakshi, HA; Hakkim, FL; Haggag, YA; Al-Batanyeh, KM; Zoubi, MSA; Al-Trad, B; Nasef, MM; Satija, S; Mehta, M; Pabreja, K; Mishra, V; Khan, M; Abobaker, S; Azzouz, IM; Dureja, H; Pabari, RM; Dardouri, AAK; Kesharwani, P; Gupta, G; Dhar Shukla, S; Prasher, P; Charbe, NB; Negi, P; Kapoor, DN; Chellappan, DK; Webba da Silva, M; Thompson, P; Dua, K; McCarron, P; Tambuwala, MM |
| 2020-01 | COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development. | Aljabali, AAA; Bakshi, HA; Satija, S; Meenu,; Prasher, P; Ennab, RM; Chellappan, DK; Gupta, G; Negi, P; Goyal, R; Sharma, A; Mishra, V; Dureja, H; Dua, K; Tambuwala, MM |
| 2021-07-01 | CRISPR-Cas9 gene editing: New hope for Alzheimer's disease therapeutics | Bhardwaj, S; Kesari, KK; Rachamalla, M; Mani, S; Ashraf, GM; Jha, SK; Kumar, P; Ambasta, RK; Dureja, H; Devkota, HP; Gupta, G; Chellappan, DK; Singh, SK; Dua, K; Ruokolainen, J; Kamal, MA; Ojha, S; Jha, NK |
| 2021-05 | Current-status and applications of polysaccharides in drug delivery systems | Prasher, P; Sharma, M; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Anand, K; Sharma, N; Dureja, H; Jha, NK; Gupta, G; Gulati, M; Singh, SK; Chellappan, DK; Paudel, KR; Hansbro, PM; Dua, K |
| 2022-12-23 | Designing and Synthesis of Green Polymeric Nanomaterials for Pharmaceutical Applications | Aljabali, AAA; Zoubi, MSA; Al-Batanyeh, KM; Alqudah, A; Obeid, MA; Prasher, P; Mishra, V; Gupta, G; Negi, P; Kapoor, DN; Dureja, H; Satija, S; Chellappan, DK; Dua, K; Tambuwala, MM |
